Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Magnesium glycerophos (magnesium 97.2mg (4mmol)) chew tab SF
0905013G0AADEDE
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 3,579 |
|
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) caps
0905013G0AAA4A4
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 1,840 |
|
Magnesium glycerophos (magnesium 97.2mg(4mmol)) chew tab
0905013G0AADDDD
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 1,471 |
|
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) caps
0905013G0AABMBM
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 1,174 |
|
Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) soln
0905013G0AADFDF
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 748 |
|
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) tab
0905013G0AAA2A2
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 384 |
|
Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) soln SF
0905013G0AADKDK
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 96 |
|
Mag glycerophos (mag 97.2mg/5ml (4mmol/5ml)) soln
0905013G0AADCDC
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 93 |
|
Mag glycerophos (magnesium 97.2mg/5ml (4mmol/5ml)) soln SF
0905013G0AADJDJ
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 38 |
|
Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) susp
0905013G0AADHDH
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 18 |
|
Magn glycerophos (mag 97.2mg/5ml (4mmol/5ml)) susp
0905013G0AACZCZ
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 9 |
|
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) caps
0905013G0AADBDB
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 3 |
|
Mag glycerophos (mag 242.5mg/5ml (10mmol/5ml)) susp
0905013G0AACYCY
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
|
Mag glycerophos (mag 97.2mg (4mmol)) oral pdr sach
0905013G0AABVBV
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
|
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) tab
0905013G0AACXCX
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
|
Magnesium glycerophosphate (magnesium 9.72mg (0.4mmol)) caps
0905013G0AADADA
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.